Swiss National Bank - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$2,217,000
+66.4%
117,542
+3.9%
0.00%
+100.0%
Q2 2019$1,332,000
-13.7%
113,1420.0%0.00%
-50.0%
Q1 2019$1,544,000
+37.4%
113,142
+3.2%
0.00%
+100.0%
Q4 2018$1,124,000
-38.4%
109,6420.0%0.00%
-50.0%
Q3 2018$1,826,000
+5.4%
109,6420.0%0.00%0.0%
Q2 2018$1,732,000
+24.4%
109,6420.0%0.00%0.0%
Q1 2018$1,392,000
+10.9%
109,6420.0%0.00%
+100.0%
Q4 2017$1,255,000
+5.3%
109,642
+12.6%
0.00%0.0%
Q3 2017$1,192,000
+56.8%
97,342
+46.7%
0.00%0.0%
Q2 2017$760,000
-44.9%
66,3420.0%0.00%
-50.0%
Q1 2017$1,380,000
+2.6%
66,342
+2.6%
0.00%0.0%
Q4 2016$1,345,000
-36.5%
64,6420.0%0.00%
-33.3%
Q3 2016$2,118,000
+33.5%
64,642
+1.7%
0.00%0.0%
Q2 2016$1,587,000
+82.8%
63,542
+72.7%
0.00%
+50.0%
Q1 2016$868,000
-6.8%
36,800
+30.5%
0.00%0.0%
Q4 2015$931,000
+0.8%
28,2000.0%0.00%0.0%
Q3 2015$924,000
-28.2%
28,200
+16.0%
0.00%
-33.3%
Q2 2015$1,287,00024,3000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders